Gsk (GSK) Return on Sales [ROS] (2009 - 2026)
Gsk's Return on Sales [ROS] was 23.93% in the quarter ended Sep 30, 2026, down 6.40 percentage points from 30.34% a year earlier but up 18.21 percentage points from the prior quarter.
Gsk (GSK) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gsk's Return on Sales [ROS] was 22.28% through Sep 30, 2026, down 1.21 percentage points year-over-year; for the year ended Dec 31, 2025, it was 24.28%, up 11.47 percentage points from the prior year.
- Return on Sales [ROS] shows a five-year change of -0.27 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, Return on Sales [ROS] was 12.82% in the year ended Dec 31, 2024 (-9.42 pp), 22.24% in the year ended Dec 31, 2023 (+0.30 pp), 21.94% in the year ended Dec 31, 2022 (+4.30 pp) and 17.64% in the year ended Dec 31, 2021 (-6.91 pp).
- Quarterly Return on Sales [ROS] has moved between 2.36% (the quarter ended Sep 30, 2024) and 31.89% (the quarter ended Mar 31, 2022) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in six of the last eight quarters, with an average year-over-year change of +4.18 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was the quarter ended Sep 30, 2025 (a gain of 27.98 percentage points); the worst was the quarter ended Sep 30, 2024 (a drop of 21.56 percentage points).
- Per Business Quant data, GSK's Return on Sales [ROS] in the three quarters before the quarter ended Sep 30, 2026 was 5.72% (quarter ended Jun 30, 2026), 30.06% (quarter ended Mar 31, 2026) and 24.28% (quarter ended Dec 31, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 23.93% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.93% |
| Jun 30, 2026 | 5.72% |
| Mar 31, 2026 | 30.06% |
| Dec 31, 2025 | 24.28% |
| Sep 30, 2025 | 30.34% |
| Jun 30, 2025 | 25.33% |
| Mar 31, 2025 | 29.48% |
| Dec 31, 2024 | 8.57% |
| Sep 30, 2024 | 2.36% |
| Jun 30, 2024 | 20.88% |
| Mar 31, 2024 | 20.24% |
| Dec 31, 2023 | 7.12% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | 29.83% |
| Mar 31, 2023 | 29.95% |
| Dec 31, 2022 | 25.33% |
| Sep 30, 2022 | 15.21% |
| Jun 30, 2022 | 15.60% |
| Mar 31, 2022 | 31.89% |
| Dec 31, 2021 | 6.95% |
Gsk Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();